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Introduction
It has earlier been shown that TLA significantly reduces
allergen exposure and airway inflammation and improves
quality of life in poorly controlled allergic asthma patients.
Aim and objective
The primary aim was to evaluate real-life effects of TLA
(Airsonett AB) when used during night-time for 12 con-
secutive months as add on to the patients’ regular
medication.
Methods
The study compared pre- versus post-TLA initiation
data from patients with poorly controlled severe persis-
tent allergic asthma. Outcome parameters were collected
at four and 12 months on medication use, asthma con-
trol, asthma symptoms, lung function, rate and use of
hospital resources due to exacerbations were collected.
Results
Data from 30 patients (mean age 28; range 8-70) complet-
ing 4 months and 27 patients completing 12 months of
TLA use, are presented. Ratios (%) or means (range) At
baseline After 12 months of TLA P-value Exacerbations
last 12 months3.6 (0-12)1.3 (0-5)0.05Asthma Control
Test14.1 (5-27)18.5 (8-27)<0.001Ratio with uncontrolled
disease, GINA55.20<0.001Ratio with controlled disease,
GINA10.333.3
Conclusion
The addition of TLA to the patients’ regular medication
significantly reduced the risk of exacerbations and the
utilization of hospital resources at disease deteriorations.
Higher proportions of patients with increased control of
asthma symptoms were also observed. The data demon-
strate that TLA may be an important new approach in
the treatment of poorly controlled allergic asthma
patients.
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